| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.3 | 2e-10 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-10 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-10 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.24 | 7e-10 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-10 |